Earnings Outlook For iSpecimen
Portfolio Pulse from Benzinga Insights
iSpecimen (NASDAQ:ISPC) is scheduled to release its quarterly earnings report on March 13, 2024, with an expected EPS of $-0.24. The company's past earnings performance shows mixed results with occasional beats and misses, and its stock price has declined by 67.56% over the last 52 weeks. Investors are looking for positive guidance for the next quarter beyond the EPS figure.
March 12, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
iSpecimen is expected to report an EPS of $-0.24 for the upcoming quarter. Historical performance shows variability in beating EPS estimates, with a significant 67.56% decline in stock price over the past year.
Given iSpecimen's mixed historical earnings performance and the significant decline in its stock price over the past year, the upcoming earnings report and particularly the future guidance provided by the company will be crucial for investors. The expected EPS of $-0.24 sets a cautious tone, but any positive guidance could potentially stabilize or uplift the stock price. However, the recent trend and the last quarter's price drop post-earnings suggest a neutral outlook in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100